-
Signature
-
/s/ Jonathan Young, Attorney-in-Fact
-
Issuer symbol
-
AKRO
-
Transactions as of
-
22 May 2025
-
Net transactions value
-
-$22,520
-
Form type
-
4
-
Filing time
-
23 May 2025, 17:30:04 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Lamy Patrick |
Senior VP, Commercial Strategy |
C/O AKERO THERAPEUTICS, INC., 601 GATEWAY BLVD, SUITE 350, SOUTH SAN FRANCISCO |
/s/ Jonathan Young, Attorney-in-Fact |
23 May 2025 |
0001961273 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
AKRO |
Common Stock |
Options Exercise |
$177,480 |
+4,000 |
+12% |
$44.37 |
37,492 |
22 May 2025 |
Direct |
F1 |
| transaction |
AKRO |
Common Stock |
Sale |
$200,000 |
-4,000 |
-11% |
$50.00 |
33,492 |
22 May 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
AKRO |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-4,000 |
-4.5% |
$0.000000 |
84,904 |
22 May 2025 |
Common Stock |
88,904 |
$44.37 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: